Core Insights - Nu Skin Enterprises, Inc. (NUS) reported disappointing third-quarter 2024 results, with both earnings and net sales falling short of Zacks Consensus Estimate, leading to a downward revision of its 2024 outlook due to ongoing macroeconomic pressures and challenges in the direct selling industry [1][10]. Financial Performance - Adjusted earnings for the third quarter were 17 cents per share, a decline from 56 cents in the same quarter last year, missing the Zacks Consensus Estimate of 20 cents [2]. - Quarterly revenues amounted to 430.1million,adecreaseof13.8301.5 million from 292.3millionyearoveryear,butgrossmargin(excludinginventorywrite−offimpact)decreasedto70.1167.6 million from 187.8millionintheprior−yearquarter,butasapercentageofrevenues,itroseto39115.6 million, down from 130.9millionyearoveryear,butasapercentageofrevenues,itincreasedto26.9227.8 million, long-term debt of 373.5million,andtotalstockholders′equityof706.9 million [8]. - The company declared a cash dividend of 6 cents per share, payable on December 11, 2024, to shareholders of record as of November 29 [9]. Future Outlook - For 2024, Nu Skin anticipates revenues between 1.70billionand1.73 billion, indicating a 12-14% decline from the previous year, with unfavorable foreign currency impacts expected to affect revenues by 4-3% [10]. - Adjusted earnings per share for 2024 are projected to be between 65-75 cents, down from 1.85in2023[11].−Forthefourthquarterof2024,thecompanyexpectsrevenuesbetween410 million and $445 million, reflecting a decline of 9% to 16% from the previous year [12].